by TractManager | Dec 11, 2019 | Clinical Utility Evaluation
This report evaluates the of prenatal and preimplantation genetic testing for risk of hearing loss.If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | Dec 10, 2019 | Health Technology Assessment
Health Problem: Approximately 20% of the U.S. population is affected by gastroesophageal reflux disease (GERD). Persistent GERD may lead to esophageal damage and may precede other serious conditions, including Barrett’s esophagus, a precancerous condition that can...
by TractManager | Dec 5, 2019 | Emerging Technology Report
Satralizumab is an investigational anti-IL-6 receptor monoclonal antibody under FDA review for the treatment of neuromyelitis optica spectrum disorder in adults and adolescents. It is administered by subcutaneous injection.If you have a Hayes login, click here to view...
by TractManager | Dec 3, 2019 | Clinical Utility Evaluation
This report evaluates the clinical utility of pharmacogenetic testing for OPRM1 and/or COMT gene variants to improve opioid treatment–related outcomes in patients with organic causes of pain.If you have a Hayes login, click here to view the full report on the...
by TractManager | Dec 3, 2019 | Health Technology Assessment
Health Problem: Esophageal achalasia (EA) is an uncommon motility disorder of unknown etiology that is characterized by increased lower esophageal sphincter (LES) pressure and esophageal aperistalsis. Treatment for EA includes both conservative treatment options, such...
Recent Comments